Жабуренето с препарат за уста ви предпазва от заразяване с 2019-nCoV

Епидемия от коронавирус 2019-nCoV: Информация и временни насоки за фармацевти и работещите в аптеки|
стр. 19 от 32
Допълнителни ресурси и информация
Библиография


Associação Nacional das Farmácias (Portugal). (January de 2020). Coronavírus 2019-nCoV: Intervenção da farmácia.
Fonte: https://www.revistasauda.pt/SiteCollectionDocuments/ANFOnline/Fluxograma_CEDIMEFinal.pdf
Centers for Disease Control and Prevention. (31 de January de 2020). 2019 Novel Coronavirus - Frequently asked
questions and answers. Fonte: https://www.cdc.gov/coronavirus/2019-ncov/faq.html
Centers for Disease Control and Prevention. (31 de January de 2020). How 2019-nCoV Spreads. Acesso em 1 de
February de 2020, disponível em CDC - 2019 Novel Coronavirus: https://www.cdc.gov/coronavirus/2019- ncov/about/transmission.html
Centers for Disease Control and Prevention. (31 de January de 2020). Interim Guidance for Healthcare Professionals.
Acesso em 1 de February de 2020, disponível em CDC - 2019 Novel Coronavirus: https://www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html#foot1
Centers for Disease Control and Prevention. (2 de February de 2020). Interim Guidelines for Collecting, Handling, and
Testing Clinical Specimens from Patients Under Investigation (PUIs) for 2019 Novel Coronavirus (2019-nCoV). Fonte: https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html
Centers for Disease Control and Prevention. (3 de February de 2020). Interim Infection Prevention and Control
Recommendations for Patients with Confirmed 2019 Novel Coronavirus (2019-nCoV) or Patients Under Investigation for
2019-nCoV in Healthcare Settings. Fonte: https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control.html
Centers for Disease Control and Prevention. (s.d.). Three Key Factors Required for a Respirator to be Effective. Fonte: https://www.cdc.gov/niosh/npptl/pdfs/KeyFactorsRequiedResp01042018-508.pdf
Chinese Pharmaceutical Association. (2020). CPA Novel Coronavirus (2019-nCoV) outbreak prevention and control:
Guidance and management strategies for pharmacists and the pharmacy workforce. Beijing: Chinese Pharmaceutical
Association.
Li, F. (29 de September de 2016). Structure, Function, and Evolution of Coronavirus Spike Proteins. Annual Review of
Virology, 3(1), 237-261. doi:10.1146/annurev-virology-110615-042301
Michelle L. Holshue, M. C.-C. (31 de January de 2020). First Case of 2019 Novel Coronavirus in the United States. New
England Journal of Medicine, NA. doi:DOI: 10.1056/NEJMoa2001191
Ministry of Health of New Zealand. (3 de February de 2020). Interim Advice for Health Professionals: Novel Coronavirus
(2019-nCoV). Fonte: https://www.health.govt.nz/system/files/documents/pages/interim_health_advice_for_health_professionals_novel_c oronavirus_wuhan_2020_02_03.pdf
Nanshan Chen, M. Z. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, NA. Acesso em 4 de February de 2020, disponível em https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30211-7/fulltext
Rothe, C. (30 de January de 2020). Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.
Fonte: New England Journal of Medicine - Correspondence: https://www.nejm.org/doi/full/10.1056/NEJMc2001468
Royal Pharmaceutical Society. (January de 2020). Wuhan novel coronavirus - Five key facts for pharmacy teams. Fonte: https://www.rpharms.com/resources/pharmacy-guides/wuhan-novel-coronavirus
World Health Organization. (April de 2010). Guide to Local Production: WHO-recommended Handrub Formulations.
Fonte: https://www.who.int/gpsc/5may/Guide_to_Local_Production.pdf
World Health Organization. (28 de January de 2020). Advice on the use of masks in the community, during home care
and in health care settings in the context of the novel coronavirus (2019-nCoV) outbreak. Fonte:

Изтегляне 1.22 Mb.

Сподели с приятели: